Abingworth as of June 30, 2021
Portfolio Holdings for Abingworth
Abingworth holds 19 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte Common (PCVX) | 28.9 | $94M | 4.2M | 22.46 | |
| Phathom Common (PHAT) | 12.6 | $41M | 1.2M | 33.85 | |
| Vera Common (VERA) | 11.9 | $39M | 3.0M | 13.01 | |
| Spruce Bio Common | 6.2 | $20M | 1.8M | 11.20 | |
| Sientra Common | 5.9 | $19M | 2.4M | 7.96 | |
| Reneo Common (RPHM) | 5.6 | $18M | 2.0M | 9.27 | |
| Sierra Oncology Common | 5.2 | $17M | 871k | 19.30 | |
| Adicet Common (ACET) | 5.1 | $17M | 1.6M | 10.26 | |
| Verona Sponds Adr (VRNA) | 4.9 | $16M | 2.5M | 6.51 | |
| Soleno Common | 3.6 | $12M | 10M | 1.13 | |
| Exicure Common | 3.2 | $10M | 7.0M | 1.49 | |
| Nucana Adr (NCNA) | 2.8 | $9.2M | 3.3M | 2.76 | |
| Paratek Common | 2.2 | $7.1M | 1.0M | 6.81 | |
| Aeglea Common | 0.5 | $1.7M | 241k | 6.95 | |
| Molecular Templates Common | 0.5 | $1.6M | 200k | 7.82 | |
| X4 Pharma Common (XFOR) | 0.5 | $1.5M | 230k | 6.50 | |
| Cymabay Common | 0.2 | $571k | 131k | 4.36 | |
| Obseva Common | 0.1 | $266k | 88k | 3.02 | |
| Ocugen Common | 0.0 | $57k | 7.1k | 8.02 |
